Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) FCF Margin: 2010-2018

Historic FCF Margin for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -2,443.42%.

  • EyePoint Pharmaceuticals' FCF Margin fell 87666.00% to -2,443.42% in Q3 2018 from the same period last year, while for Sep 2018 it was -1,465.95%, marking a year-over-year decrease of 120202.00%. This contributed to the annual value of -743.50% for FY2018, which is 46976.00% down from last year.
  • As of Q3 2018, EyePoint Pharmaceuticals' FCF Margin stood at -2,443.42%, which was down 59.62% from -1,530.77% recorded in Q2 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' FCF Margin peaked at 4,074.66% during Q4 2014, and registered a low of -5,038.00% during Q4 2017.
  • For the 3-year period, EyePoint Pharmaceuticals' FCF Margin averaged around -1,611.98%, with its median value being -1,445.07% (2016).
  • Its FCF Margin has fluctuated over the past 5 years, first spiked by 445,811bps in 2014, then tumbled by 495,403bps in 2017.
  • EyePoint Pharmaceuticals' FCF Margin (Quarterly) stood at 4,074.66% in 2014, then slumped by 468,284bps to -608.17% in 2015, then soared by 52,420bps to -83.97% in 2016, then tumbled by 495,403bps to -5,038.00% in 2017, then plummeted by 87,666bps to -2,443.42% in 2018.
  • Its last three reported values are -2,443.42% in Q3 2018, -1,530.77% for Q2 2018, and -519.18% during Q1 2018.